KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.
The US private equity firm is looking to hire financial advisers to help evaluate a sale of its 53.8% stake in the Mumbai-based company, the people said, asking not to be identified as the matter is private. Other buyout firms and industry players have shown preliminary interest in buying KKR’s stake, the people said.
Shares of the company, which is known as JB Pharma, have climbed 68% in the past 12 months, valuing the firm at just over $3 billion.
Can’t stop reading? Read more
DWS outlines $6tn investment need in European infrastructure, positioning mid-cap strategy as core to long-term resilience
DWS outlines $6tn investment need in European infrastructure, positioning mid-cap strategy as core...
Top private equity news of the week
Top private equity news of the week Apollo Global Management is in advanced discussions to acquire...
Fund Friday: Top fundraising news in private equity
Fund Friday: Top fundraising news in private equity Neuberger Berman has held the final close of...